Cite Them Right 11th edition - Harvard

Borst, N., Ihorst, G., Wenger, S., Räder, J., Wäsch, R., Engelhardt, M. und Rassner, M. (2024) Clinical characteristics, cytogenetic risks, and prognoses of young multiple myeloma patients in the era of novel therapies [cd]. Freiburg: Universität. doi:10.3390/cancers16234090.

Chicago Manual of Style 17th edition (full note)

Borst, Nathalie, Gabriele Ihorst, Sina Wenger, Jan Räder, Ralph Wäsch, Monika Engelhardt, und Michael Rassner. Clinical characteristics, cytogenetic risks, and prognoses of young multiple myeloma patients in the era of novel therapies. Cd. Freiburg: Universität, [2024?], Freiburg: Universität, [2024?]. https://doi.org/10.3390/cancers16234090.

American Psychological Association 7th edition

Borst, N., Ihorst, G., Wenger, S., Räder, J., Wäsch, R., Engelhardt, M., & Rassner, M. (ca. 2024). Clinical characteristics, cytogenetic risks, and prognoses of young multiple myeloma patients in the era of novel therapies [Cd]. Universität. https://doi.org/10.3390/cancers16234090

Modern Language Association 9th edition

Borst, N., G. Ihorst, S. Wenger, J. Räder, R. Wäsch, M. Engelhardt, und M. Rassner. Clinical characteristics, cytogenetic risks, and prognoses of young multiple myeloma patients in the era of novel therapies. cd, Universität, 2024, https://doi.org/10.3390/cancers16234090.

ISO-690 (author-date, Deutsch)

BORST, Nathalie, Gabriele IHORST, Sina WENGER, Jan RÄDER, Ralph WÄSCH, Monika ENGELHARDT und Michael RASSNER, 2024. Clinical characteristics, cytogenetic risks, and prognoses of young multiple myeloma patients in the era of novel therapies. Freiburg: Universität

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.